Correlation Between Savara and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Savara and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Savara and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Savara Inc and Aerovate Therapeutics, you can compare the effects of market volatilities on Savara and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Savara with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Savara and Aerovate Therapeutics.
Diversification Opportunities for Savara and Aerovate Therapeutics
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Savara and Aerovate is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Savara Inc and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Savara is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Savara Inc are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Savara i.e., Savara and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Savara and Aerovate Therapeutics
Given the investment horizon of 90 days Savara Inc is expected to under-perform the Aerovate Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Savara Inc is 2.07 times less risky than Aerovate Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Aerovate Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 1,665 in Aerovate Therapeutics on September 2, 2024 and sell it today you would lose (1,402) from holding Aerovate Therapeutics or give up 84.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Savara Inc vs. Aerovate Therapeutics
Performance |
| Timeline |
| Savara Inc |
| Aerovate Therapeutics |
Savara and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Savara and Aerovate Therapeutics
The main advantage of trading using opposite Savara and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Savara position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Savara vs. Stoke Therapeutics | Savara vs. Edgewise Therapeutics | Savara vs. Crinetics Pharmaceuticals | Savara vs. Dyne Therapeutics |
| Aerovate Therapeutics vs. Tff Pharmaceuticals | Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. Inhibrx | Aerovate Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |